Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing precisely xylometazoline hydrochloride 1 milligram/1 milliliter conventional release nasal drops (clinical drug) |
Is a |
False |
Xylometazoline hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Xylometazoline hydrochloride 0.05% pediatric nasal drops |
Is a |
False |
Xylometazoline hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Xylometazoline hydrochloride 1 mg/mL nasal spray |
Is a |
False |
Xylometazoline hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely xylometazoline hydrochloride 1 milligram/1 milliliter conventional release nasal drops (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xylometazoline hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Xylometazoline hydrochloride 0.05% pediatric nasal drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xylometazoline hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Xylometazoline hydrochloride 1 mg/mL nasal spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xylometazoline hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Xylometazoline hydrochloride 344.48 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xylometazoline hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Xylometazoline hydrochloride 0.05% nasal spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xylometazoline hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xylometazoline hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xylometazoline hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium cromoglycate+xylometazoline hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xylometazoline hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Antazoline sulfate+xylometazoline hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xylometazoline hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Antazoline- and xylometazoline-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xylometazoline hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Xylometazoline hydrochloride 344.48 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Xylometazoline hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Xylometazoline hydrochloride 344.48 mg oral capsule |
Has basis of strength substance (attribute) |
True |
Xylometazoline hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Xylometazoline hydrochloride 344.48 mg oral capsule |
Has precise active ingredient |
True |
Xylometazoline hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely xylometazoline hydrochloride 1 milligram/1 milliliter conventional release nasal drops (clinical drug) |
Has basis of strength substance (attribute) |
True |
Xylometazoline hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely xylometazoline hydrochloride 1 milligram/1 milliliter conventional release nasal drops (clinical drug) |
Has precise active ingredient |
True |
Xylometazoline hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray (clinical drug) |
Has precise active ingredient |
False |
Xylometazoline hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray (clinical drug) |
Has basis of strength substance (attribute) |
False |
Xylometazoline hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Xylometazoline hydrochloride 1 mg/mL nasal spray |
Has precise active ingredient |
True |
Xylometazoline hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Xylometazoline hydrochloride 1 mg/mL nasal spray |
Has basis of strength substance (attribute) |
True |
Xylometazoline hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops (clinical drug) |
Has precise active ingredient |
True |
Xylometazoline hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops (clinical drug) |
Has basis of strength substance (attribute) |
True |
Xylometazoline hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely xylometazoline hydrochloride 500 microgram/1 milliliter conventional release solution for nasal drops |
Has basis of strength substance (attribute) |
False |
Xylometazoline hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely xylometazoline hydrochloride 500 microgram/1 milliliter conventional release solution for nasal drops |
Has precise active ingredient |
False |
Xylometazoline hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely xylometazoline hydrochloride 500 microgram/1 milliliter conventional release nasal drops (clinical drug) |
Has precise active ingredient |
True |
Xylometazoline hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely xylometazoline hydrochloride 500 microgram/1 milliliter conventional release nasal drops (clinical drug) |
Has basis of strength substance (attribute) |
True |
Xylometazoline hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray (clinical drug) |
Has precise active ingredient |
True |
Xylometazoline hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray (clinical drug) |
Has basis of strength substance (attribute) |
True |
Xylometazoline hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Xylometazoline hydrochloride 140 microgram/actuation nasal spray |
Has precise active ingredient |
True |
Xylometazoline hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Xylometazoline hydrochloride 140 microgram/actuation nasal spray |
Has basis of strength substance (attribute) |
True |
Xylometazoline hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |